Clinical Trials Browser

Recruiting × Melanoma × Imatinib Mesylate × Clear all

NCT04598009 2025-09-03

Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma

Phase 2 Recruiting

Melanoma